哺乳动物细胞的核苷转运体。

Q4 Pharmacology, Toxicology and Pharmaceutics Pharmaceutical biotechnology Pub Date : 1999-01-01 DOI:10.1007/0-306-46812-3_12
C E Cass, J D Young, S A Baldwin, M A Cabrita, K A Graham, M Griffiths, L L Jennings, J R Mackey, A M Ng, M W Ritzel, M F Vickers, S Y Yao
{"title":"哺乳动物细胞的核苷转运体。","authors":"C E Cass,&nbsp;J D Young,&nbsp;S A Baldwin,&nbsp;M A Cabrita,&nbsp;K A Graham,&nbsp;M Griffiths,&nbsp;L L Jennings,&nbsp;J R Mackey,&nbsp;A M Ng,&nbsp;M W Ritzel,&nbsp;M F Vickers,&nbsp;S Y Yao","doi":"10.1007/0-306-46812-3_12","DOIUrl":null,"url":null,"abstract":"<p><p>In this review, we have summarized recent advances in our understanding of the biology of nucleoside transport arising from new insights provided by the isolation and functional expression of cDNAs encoding the major nucleoside transporters of mammalian cells. Nucleoside transporters are required for permeation of nucleosides across biological membranes and are present in the plasma membranes of most cell types. There is growing evidence that functional nucleoside transporters are required for translocation of nucleosides between intracellular compartments and thus are also present in organellar membranes. Functional studies during the 1980s established that nucleoside transport in mammalian cells occurs by two mechanistically distinct processes, facilitated diffusion and Na(+)-nucleoside cotransport. The determination of the primary amino acid sequences of the equilibrative and concentrative transporters of human and rat cells has provided a structural basis for the functional differences among the different transporter subtypes. Although nucleoside transporter proteins were first purified from human erythrocytes a decade ago, the low abundance of nucleoside transporter proteins in membranes of mammalian cells has hindered analysis of relationships between transporter structure and function. The molecular cloning of cDNAs encoding nucleoside transporters and the development of heterologous expression systems for production of recombinant nucleoside transporters, when combined with recombinant DNA technologies, provide powerful tools for characterization of functional domains within transporter proteins that are involved in nucleoside recognition and translocation. As relationships between molecular structure and function are determined, it should be possible to develop new approaches for optimizing the transportability of nucleoside drugs into diseased tissues, for development of new transport inhibitors, including reagents that are targeted to the concentrative transporters, and, eventually, for manipulation of transporter function through an understanding of the regulation of transport activity.</p>","PeriodicalId":19777,"journal":{"name":"Pharmaceutical biotechnology","volume":"12 ","pages":"313-52"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/0-306-46812-3_12","citationCount":"148","resultStr":"{\"title\":\"Nucleoside transporters of mammalian cells.\",\"authors\":\"C E Cass,&nbsp;J D Young,&nbsp;S A Baldwin,&nbsp;M A Cabrita,&nbsp;K A Graham,&nbsp;M Griffiths,&nbsp;L L Jennings,&nbsp;J R Mackey,&nbsp;A M Ng,&nbsp;M W Ritzel,&nbsp;M F Vickers,&nbsp;S Y Yao\",\"doi\":\"10.1007/0-306-46812-3_12\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this review, we have summarized recent advances in our understanding of the biology of nucleoside transport arising from new insights provided by the isolation and functional expression of cDNAs encoding the major nucleoside transporters of mammalian cells. Nucleoside transporters are required for permeation of nucleosides across biological membranes and are present in the plasma membranes of most cell types. There is growing evidence that functional nucleoside transporters are required for translocation of nucleosides between intracellular compartments and thus are also present in organellar membranes. Functional studies during the 1980s established that nucleoside transport in mammalian cells occurs by two mechanistically distinct processes, facilitated diffusion and Na(+)-nucleoside cotransport. The determination of the primary amino acid sequences of the equilibrative and concentrative transporters of human and rat cells has provided a structural basis for the functional differences among the different transporter subtypes. Although nucleoside transporter proteins were first purified from human erythrocytes a decade ago, the low abundance of nucleoside transporter proteins in membranes of mammalian cells has hindered analysis of relationships between transporter structure and function. The molecular cloning of cDNAs encoding nucleoside transporters and the development of heterologous expression systems for production of recombinant nucleoside transporters, when combined with recombinant DNA technologies, provide powerful tools for characterization of functional domains within transporter proteins that are involved in nucleoside recognition and translocation. As relationships between molecular structure and function are determined, it should be possible to develop new approaches for optimizing the transportability of nucleoside drugs into diseased tissues, for development of new transport inhibitors, including reagents that are targeted to the concentrative transporters, and, eventually, for manipulation of transporter function through an understanding of the regulation of transport activity.</p>\",\"PeriodicalId\":19777,\"journal\":{\"name\":\"Pharmaceutical biotechnology\",\"volume\":\"12 \",\"pages\":\"313-52\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1007/0-306-46812-3_12\",\"citationCount\":\"148\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmaceutical biotechnology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/0-306-46812-3_12\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical biotechnology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/0-306-46812-3_12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 148

摘要

在这篇综述中,我们总结了最近我们对核苷转运生物学的理解的进展,这些进展来自于编码哺乳动物细胞主要核苷转运蛋白的cdna的分离和功能表达。核苷转运体是核苷通过生物膜渗透所必需的,并且存在于大多数细胞类型的质膜中。越来越多的证据表明功能性核苷转运体是核苷在细胞内区室之间转运所必需的,因此也存在于细胞器膜中。20世纪80年代的功能研究证实,核苷在哺乳动物细胞中的转运通过两种机制不同的过程发生,即促进扩散和Na(+)-核苷共转运。人类和大鼠细胞中平衡转运蛋白和集中转运蛋白一级氨基酸序列的测定,为不同转运蛋白亚型之间的功能差异提供了结构基础。虽然核苷转运蛋白在十年前首次从人红细胞中纯化出来,但哺乳动物细胞膜中核苷转运蛋白的低丰度阻碍了转运蛋白结构和功能之间关系的分析。编码核苷转运体的cdna的分子克隆和用于生产重组核苷转运体的异源表达系统的开发,与重组DNA技术相结合,为表征转运蛋白中涉及核苷识别和易位的功能域提供了强大的工具。随着分子结构和功能之间关系的确定,应该有可能开发新的方法来优化核苷类药物进入病变组织的可转运性,开发新的转运抑制剂,包括针对浓缩转运蛋白的试剂,并最终通过理解转运活性的调节来操纵转运蛋白功能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Nucleoside transporters of mammalian cells.

In this review, we have summarized recent advances in our understanding of the biology of nucleoside transport arising from new insights provided by the isolation and functional expression of cDNAs encoding the major nucleoside transporters of mammalian cells. Nucleoside transporters are required for permeation of nucleosides across biological membranes and are present in the plasma membranes of most cell types. There is growing evidence that functional nucleoside transporters are required for translocation of nucleosides between intracellular compartments and thus are also present in organellar membranes. Functional studies during the 1980s established that nucleoside transport in mammalian cells occurs by two mechanistically distinct processes, facilitated diffusion and Na(+)-nucleoside cotransport. The determination of the primary amino acid sequences of the equilibrative and concentrative transporters of human and rat cells has provided a structural basis for the functional differences among the different transporter subtypes. Although nucleoside transporter proteins were first purified from human erythrocytes a decade ago, the low abundance of nucleoside transporter proteins in membranes of mammalian cells has hindered analysis of relationships between transporter structure and function. The molecular cloning of cDNAs encoding nucleoside transporters and the development of heterologous expression systems for production of recombinant nucleoside transporters, when combined with recombinant DNA technologies, provide powerful tools for characterization of functional domains within transporter proteins that are involved in nucleoside recognition and translocation. As relationships between molecular structure and function are determined, it should be possible to develop new approaches for optimizing the transportability of nucleoside drugs into diseased tissues, for development of new transport inhibitors, including reagents that are targeted to the concentrative transporters, and, eventually, for manipulation of transporter function through an understanding of the regulation of transport activity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
期刊最新文献
Molecular Biology Agitation and Aeration Molecular Biology Tools Vaccines Antibody-Based Biotherapeutics in Inflammatory Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1